BioCardia, Inc.
BCDANASDAQHealthcareBiotechnology
As of Oct 22, 2026 close
- Market cap
- $11.23M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.75$1.80
- Volume (live)
- -
- Avg. volume (3M)
- 239.46K
BioCardia (BCDA) Stock Price & Financial Analysis
BioCardia Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.91 - $0.95 |
|---|---|
| 52-Week High | $1.80 |
| 52-Week Low | $0.75 |
| Open | $0.95 |
| Volume (last close) | 40.28K |
| Average Volume (3M) | 239.46K |
| 50-Day MA | $1.05 |
|---|---|
| 200-Day MA | $1.09 |
| 1-Year Change | −33.43% |
| Market Cap | 11.23M |
|---|---|
| Shares Outstanding | 12.09M |
| Price to Book (P/B) | 4.16 |
| EV/EBITDA | -1.00 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
BioCardia at a Glance
As of the Oct 23, 2026 close, BioCardia (BCDA) has a market capitalization of $11.23M. Revenue fell 100.0% year over year.
As of its latest reported balance sheet, it holds $4.12M in cash and securities against $293.00K of debt, a net cash position of $3.82M.
BioCardia does not currently pay a dividend.
The share price is down 33.4% over the past year. At $0.92 (the Oct 23, 2026 close) it sits within its 52-week range of $0.75 to $1.80, below its 200-day moving average of $1.09.
Frequently Asked Questions About BioCardia
What is the current stock price for BCDA?
As of the Oct 23, 2026 close, BCDA stock trades at $0.92. The 52-week range is $0.75–$1.80, with a day range of $0.91–$0.95.
What is the P/E ratio for BCDA?
The P/E ratio (Price-to-Earnings) for BCDA is shown in the Key Statistics section. This valuation metric helps compare BioCardia, Inc. to industry peers.
Does BCDA pay dividends?
BioCardia does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for BCDA?
Analyst ratings and recommendations for BCDA are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of BCDA?
As of the Oct 23, 2026 close, BioCardia's market capitalization is $11.1M, classifying it as a micro-cap company. BioCardia operates in the Healthcare sector within the Biotechnology industry.